Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

CMS cuts hospital outpatient rates in final rule

CMS plans to cut $380 million in 2019 by establishing site-neutral payments to hospitals. The change, which was outlined in CMS’ Outpatient Prospective Payment System final rule on Friday, will lower out-of-pocket costs for beneficiaries but also reduce payments for hospital-owned outpatient settings.

Thumbnail

HHS drug pricing advisor dies

Daniel Best, a senior advisor to HHS Secretary Alex Azar, passed away, the agency announced. He worked with HHS on drug pricing reform.

Thumbnail

CMS finalizes physician fee schedule, delaying controversial coding change

CMS finalized the Physician Fee Schedule and Quality Payment Program, delaying a controversial coding change that would have resulted in a payment cut for doctors.

NIPS slip: AI’s biggest conference has a name problem

There’s an ongoing debate about changing the name of AI’s most prominent conference that some say contribute to the field’s diversity issues and inspires sexual jokes, according to a report by Wired.

Thumbnail

Head of CMS says Medicare for all is 'scary'

CMS Administrator Seema Verma further waded into the debate over Medicare for all on Halloween when she tweeted an image of a "Medicare for all" T-shirt with the comment that it's the “scariest Halloween costume" of the year.

Thumbnail

CMS finalizes new payment model for home health, boosts reimbursements for 2019

CMS finalized the 2019 home health prospective payment system, cementing a new payment model for the post-acute care space in 2020 and increasing payments for 2019.

Thumbnail

FDA clears 23andMe genetic testing to market on drug metabolism

The FDA will allow genetic testing company 23andMe to market personal genome reports as a direct-to-consumer test of a person’s ability to metabolize some medications to help inform discussions with healthcare providers.

Thumbnail

Maine health systems to combine into $3B entity

The hospital and other healthcare provider members of MaineHealth in Portland, Maine, will combine into one nonprofit entity beginning Jan. 1.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.